Aveanna Healthcare Holdings (AVAH) Gains from Sales and Divestitures (2022 - 2026)

Aveanna Healthcare Holdings has reported Gains from Sales and Divestitures for 4 years, with the latest figure at $5.7 million in Q1 2026.

• For the quarter ending Q1 2026, Gains from Sales and Divestitures rose 728.53% year-over-year to $5.7 million; the trailing twelve-month figure through Jan 2026 stood at $5.7 million (up 728.53% YoY), and the FY2026 full-year result was $5.7 million, up 728.53% from the prior year.
• Gains from Sales and Divestitures for Q1 2026 stood at $5.7 million, up from $688865.0 in the prior quarter.
• The five-year high for Gains from Sales and Divestitures was $5.7 million in Q1 2026, with the low at $308055.0 in Q4 2023.
• Historically, Gains from Sales and Divestitures has averaged $1.8 million across 4 years, with a median of $504959.0 in 2022.
• Annual changes were most pronounced in 2023 — Gains from Sales and Divestitures retreated 4.05% — and 2026, when it soared 728.53%.
• Aveanna Healthcare Holdings' Gains from Sales and Divestitures stood at $321053.0 in 2022, then dropped by 4.05% to $308055.0 in 2023, then soared by 123.62% to $688865.0 in 2024, then surged by 728.53% to $5.7 million in 2026.
• The last three Gains from Sales and Divestitures figures came in at $5.7 million (Q1 2026), $688865.0 (Q4 2024), and $308055.0 (Q4 2023), per Business Quant data.